Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Biora Therapeutics Inc (BIOR)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biora Therapeutics's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.600 -0.043    -6.63%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
0.650
+0.050
+8.317%
19:05:52 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 516,532
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.585 - 0.679
Biora Therapeutics 0.600 -0.043 -6.63%

BIOR Balance Sheet

 
Featured here, the Balance Sheet for Biora Therapeutics Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 19.07 19.25 33.88 37.17
Cash and Short Term Investments 15.21 12.57 26.45 30.46
Cash - - - -
Cash & Equivalents 15.21 12.57 26.45 30.46
Short Term Investments - - - -
Total Receivables, Net 0.83 0.818 0.819 0.828
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 3.03 3.18 3.91 3.06
Other Current Assets, Total - 2.68 2.7 2.82
Total Assets 31.22 34.7 49.67 53.24
Property/Plant/Equipment, Total - Net 2.77 3.07 3.24 3.74
Property/Plant/Equipment, Total - Gross - 5.47 5.64 6.04
Accumulated Depreciation, Total - -2.4 -2.4 -2.29
Goodwill, Net 6.07 6.07 6.07 6.07
Intangibles, Net - - - -
Long Term Investments - 6 6 6
Note Receivable - Long Term 0.83 0.818 0.819 0.828
Other Long Term Assets, Total 3.3 0.314 0.478 0.259
Other Assets, Total -0.83 1.86 1.88 1.99
Total Current Liabilities 62.97 69.54 37.67 25.08
Accounts Payable 2.84 3.9 5.04 3.42
Payable/Accrued - - - -
Accrued Expenses 17.32 10.92 8.21 6.47
Notes Payable/Short Term Debt - 0.959 1.52 0.502
Current Port. of LT Debt/Capital Leases 1.98 0.962 0.81 0.89
Other Current liabilities, Total 40.83 52.8 22.09 13.8
Total Liabilities 132.64 153.49 170.55 158.24
Total Long Term Debt 43.74 80.38 128.57 128.18
Long Term Debt 43.74 80.38 128.57 128.18
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 25.13 1.65 1.28 3.97
Total Equity -101.42 -118.79 -120.88 -105
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.025 0.021 0.011 0.011
Additional Paid-In Capital 868.59 835.82 760.28 758.35
Retained Earnings (Accumulated Deficit) -950.96 -935.54 -862.09 -844.28
Treasury Stock - Common -19.08 -19.08 -19.08 -19.08
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 31.22 34.7 49.67 53.24
Total Common Shares Outstanding 27.84 23.41 13.42 11.86
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BIOR Comments

Write your thoughts about Biora Therapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Piewhi Van Hirtum
Piewhi Van Hirtum Jan 24, 2024 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What do you think about this stock? invest or pass...
Reply
0 0
Report
Piewhi Van Hirtum
Piewhi Van Hirtum Jan 24, 2024 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Pre-Market Time (ET) Pre-Market Price Pre-Market Share Volume 07:21:28 $0.9987 1 07:21:28 $0.9986 5 07:21:28 $0.971 19 07:14:22 $0.971 1 04:27:43 $0.77 29 04:24:06 $0.9 1 04:24:06 $0.9711 7
Reply
0 0
Report
Merter Ortac
Merter Ortac Dec 21, 2023 2:36PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Phase I will rocket
Reply
0 0
Report
LUCA FARRI
LUCA FARRI Apr 15, 2023 2:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong Buy
Reply
1 0
Report
LUCA FARRI
LUCA FARRI Apr 15, 2023 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Analyst Price TargetAverage82.500 (+3,073.077% Upside)High100.000Low65.000Price2.600No. of Analysts2
Reply
1 0
Report
John Mulhere
John Mulhere Jan 12, 2023 9:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Squeeze here @ $5.30
Reply
1 0
Report
Сергей Варяг
Сергей Варяг Jan 12, 2023 9:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
do you think it will go up from $5:30 ?
Reply
0 0
Report
tomppa aho
tomppa aho Jan 10, 2023 6:51PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
squueze?
Reply
2 1
Report
Sharon Martin
Sharon Martin Aug 10, 2022 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hello. What should we do???
Reply
0 1
Report
Mary Hill
Mary Hill Aug 10, 2022 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
DYOR
Reply
0 0
Report
Giuseppe Giannachi
Giuseppe Giannachi Aug 10, 2022 10:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hello...
Reply
0 1
Report
Giuseppe Giannachi
Giuseppe Giannachi Mar 29, 2022 5:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Wow! PROG got hit hard after earnings, but the product advancements seem positive. Any ideas on today, people? Thanks!
Reply
0 1
Report
Tony De Witte
Tony De Witte Jan 11, 2022 10:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Progenity kondigt mondelinge presentatie aan over behandeling van gastro-intestinale aandoeningen tijdens 34e Belgische Week van de gastro-enterologie
Reply
1 2
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email